News & Events
BD Initiates Voluntary Recall of Certain BD™ Test Strips
|
Contact: Colleen T. White Corporate Communications (201) 847-5369 Email: colleen_white@bd.com Patricia A. Spinella Investor Relations (201) 847-5453 Email: patricia_spinella@bd.com Franklin Lakes, NJ (January 29, 2004) -- BD (Becton, Dickinson and Company)(NYSE:BDX) announced today that it has initiated a voluntary product recall of certain lots of its BD™ Test Strips used for blood glucose monitoring. These lots may produce an increased frequency of "E-3" messages when used during blood glucose testing.
The E-3 message is a protective feature of the meter that appears during a test to indicate issues with the application of a blood sample or with the test strip. This message does not cause erroneous test results, as no test result is shown when the E-3 message is displayed. To maintain the highest product quality standards and ensure customer satisfaction, BD is performing this recall and replacing strips from all affected lots. BD has a sufficient remaining quantity of test strips in inventory to replace the recalled product and to continue supplying the market.
BD is informing its customers, including distributors, retailers and healthcare professionals, about this situation and has outlined steps for replacement of test strips from affected lots.
Patient safety and the efficacy of its products are BD's first priorities. Customers with questions or concerns can call BD toll-free at 1-866-556-8123.
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. For the fiscal year ended September 30, 2003, BD reported total revenues of $4.528 billion.
|